TG Therapeutics
TGTX
#2873
Rank
NZ$7.86 B
Marketcap
$50.50
Share price
-4.23%
Change (1 day)
170.14%
Change (1 year)

Revenue for TG Therapeutics (TGTX)

Revenue in 2024 (TTM): NZ$0.57 Billion

According to TG Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0.59 Billion. In 2023 the company made a revenue of NZ$0.36 Billion an increase over the revenue in the year 2022 that were of NZ$4.38 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TG Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.57 B55.11%
2023 NZ$0.36 B8326.24%
2022 NZ$4.38 M-55.22%
2021 NZ$9.79 M4548.69%
2020 NZ$0.21 M-6.66%
2019 NZ$0.22 M-0.4%
2018 NZ$0.22 M5.81%
2017 NZ$0.21 M-2.65%
2016 NZ$0.21 M-1.19%
2015 NZ$0.22 M14.48%
2014 NZ$0.19 M4.88%
2013 NZ$0.18 M700.84%
2012 NZ$0.02 M
2011 N/A
2010 N/A
2009 N/A
2000 NZ$12.09 M426.64%
1999 NZ$2.29 M-62.18%
1998 NZ$6.07 M1074.55%
1997 NZ$0.51 M21.75%
1996 NZ$0.42 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$5.92 B 898.96%๐Ÿ‡ฎ๐Ÿ‡ณ India
NZ$2.57 B 334.10%๐Ÿ‡ฎ๐Ÿ‡ช Ireland